Ealixir, Inc.

OTC:EAXR

2.25 (USD) • At close November 14, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201020092008200720062005200420032002200120001999199819971996
Revenue 5.0524.143.5381.6711.3234.06134.3370.9661.6212.4331.8061.3382.3446.1075.5481.462.10.9620.1970
Cost of Revenue 1.3070.8770.8640.6240.80332.49734.9960.0610.3020.4450.3630.3240.9293.6954.0960.980.60.5310.1590
Gross Profit 3.7443.2632.6741.0470.5171.563-0.6590.9051.3191.9881.4431.0151.4152.4121.4520.481.50.4320.0380
Gross Profit Ratio 0.7410.7880.7560.6270.3920.046-0.0190.9370.8140.8170.7990.7580.6040.3950.2620.3290.7140.4490.1920
Reseach & Development Expenses 00000000.2340.7811.0650.5260.6480.721.4751.2280.6010.80.7550.5450
General & Administrative Expenses 4.72.9392.8441.44805.26.95400000000002.4063.9070
Selling & Marketing Expenses 0.020.0540.159-0.00100000000000002.1341.0230
SG&A 4.722.9923.5561.4471.3025.26.9541.6592.1172.4291.7082.5573.3197.6810.5625.0365.84.544.9310.001
Other Expenses 000.35800000000000000000
Operating Expenses 4.722.9923.5561.4471.3028.2710.1277.1783.3323.5552.1053.4065.35221.44513.8015.4626.85.2955.7490.023
Operating Income -0.9760.27-0.882-0.4-0.785-6.707-10.785-6.273-2.012-1.567-0.662-2.392-3.937-19.034-12.349-4.983-5.3-4.863-5.711-0.023
Operating Income Ratio -0.1930.065-0.249-0.239-0.595-0.197-0.314-6.494-1.241-0.644-0.367-1.787-1.68-3.117-2.226-3.413-2.524-5.053-29.0080
Total Other Income Expenses Net -0.39-0.110.597-0.038-0.514-18.702-0.454-1.131-0.4810.1330.2570.0111.123-8.0350.4160.7360.80-0.1440
Income Before Tax -1.3660.16-0.285-0.438-1.3-25.408-11.239-7.404-2.493-1.434-0.405-2.38-2.814-27.069-11.933-4.247-4.50-5.8550
Income Before Tax Ratio -0.270.039-0.081-0.262-0.985-0.746-0.327-7.665-1.538-0.589-0.224-1.778-1.2-4.432-2.151-2.909-2.1430-29.7390
Income Tax Expense -0.5160.020.0480.0830.03422.1593.777-5.2830.051-0.133-0.008-0.14-0.468-0.589-0.927-0.736-0.9-0.831-0.4020.023
Net Income -0.8510.14-0.335-0.521-1.334-28.866-14.562-2.121-2.063-1.434-0.654-2.252-3.432-18.444-11.293-4.247-4.4-4.032-5.309-0.023
Net Income Ratio -0.1680.034-0.095-0.312-1.011-0.847-0.424-2.196-1.272-0.589-0.362-1.682-1.464-3.02-2.036-2.909-2.095-4.189-26.9660
EPS -0.0150.003-0.007-0.014-95.25-8,639.86-7,762.4-24,102.27-29,898.38-23,123.6-14,534.51-50,037.44-83,715.85-542,484.65-342,223.67-151,676.75-488,888.89-503,975.5-758,487.29-3,232
EPS Diluted -0.0150.003-0.007-0.014-95.25-8,639.86-7,762.4-24,102.27-29,898.38-23,123.6-14,534.51-50,037.44-83,715.85-542,484.65-342,223.67-151,676.75-488,888.89-503,975.5-758,487.29-3,232
EBITDA -0.8910.346-0.84-0.4-0.78514.617-8.748-5.142-1.529-1.639-0.786-2.124-3.747-7.015-10.755-5.893-5.9-4.293-5.03-0.023
EBITDA Ratio -0.1760.084-0.238-0.239-0.5950.429-0.255-5.323-0.943-0.674-0.435-1.587-1.598-1.149-1.938-4.037-2.81-4.46-25.5470